Xeris Pharmaceuticals Stock Options

XERS Stock  USD 3.54  0.07  1.94%   
Xeris Pharmaceuticals' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 0.8. The Xeris Pharmaceuticals option chain provides detailed quote and price information for the current Xeris Pharmaceuticals option contracts. It shows all of Xeris Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.

In The Money vs. Out of Money Option Contracts on Xeris Pharmaceuticals

Analyzing Xeris Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Xeris Pharmaceuticals regardless of its overall volatility. This is especially true when Xeris Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Xeris Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Xeris Pharmaceuticals' stock while costing only a fraction of its price.

Xeris Current Options Market Mood

Xeris Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Xeris Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Volume

Unfortunately, most Xeris Pharmaceuticals' options investors are not very successful. Xeris Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Xeris contract

Base on the Rule 16, the options market is currently suggesting that Xeris Pharmaceuticals will have an average daily up or down price movement of about 0.05% per day over the life of the 2025-01-17 option contract. With Xeris Pharmaceuticals trading at USD 3.54, that is roughly USD 0.00177. If you think that the market is fully incorporating Xeris Pharmaceuticals' daily price movement you should consider buying Xeris Pharmaceuticals options at the current volatility level of 0.8%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Xeris Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Xeris calls. Remember, the seller must deliver Xeris Pharmaceuticals stock to the call owner when a call is exercised.

Xeris Pharmaceuticals Option Chain

When Xeris Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Xeris Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Xeris Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Xeris. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Xeris. It also shows strike prices and maturity days for a Xeris Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
XERS250117C0000050000.50.9 - 1.90.9Out
Call
XERS250117C0000100001.00.5 - 1.50.5Out
Call
XERS250117C0000150001.50.25 - 1.250.25Out
Call
XERS250117C0000200002.00.05 - 1.050.05Out
Call
XERS250117C0000250002.50.05 - 0.550.05Out
Call
XERS250117C0000500005.00.0 - 0.50.5Out
Call
XERS250117C0000750007.50.0 - 5.05.0Out
 Put
XERS250117P0000050000.50.0 - 1.01.0Out
 Put
XERS250117P0000100001.00.0 - 1.01.0Out
 Put
XERS250117P0000150001.50.0 - 1.01.0Out
 Put
XERS250117P0000200002.00.0 - 1.01.0Out
 Put
XERS250117P0000250002.50.6 - 0.80.6Out
 Put
XERS250117P0000500005.00.6 - 5.50.6Out
 Put
XERS250117P0000750007.53.5 - 8.03.5Out

Xeris Pharmaceuticals Market Cap Over Time

   Market Cap   
       Timeline  

Xeris Total Stockholder Equity

Total Stockholder Equity

(7.41 Million)

At this time, Xeris Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year.

Xeris Pharmaceuticals Corporate Management

PharmD DSenior AffairsProfile
Beth JDChief SecretaryProfile
Steven PieperChief OfficerProfile
Dr MBACoFounder OfficerProfile
Paul JDSenior AdvisorProfile

Additional Tools for Xeris Stock Analysis

When running Xeris Pharmaceuticals' price analysis, check to measure Xeris Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xeris Pharmaceuticals is operating at the current time. Most of Xeris Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Xeris Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xeris Pharmaceuticals' price. Additionally, you may evaluate how the addition of Xeris Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.